Mapping the differential distribution of proteoglycan core proteins in the adult human retina, choroid, and sclera

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 12, 2012, Pages 7528-7538

  Keenan, Tiarnan D L ^a,c,d   Clark, Simon J ^a,d   Unwin, Richard D ^d   Ridge, Liam A ^b   Day, Anthony J ^b   Bishop, Paul N ^a,c,d  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

^d MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; AGRIN; BIGLYCAN; CD44V ANTIGEN; COLLAGEN TYPE 18; DECORIN; FIBROMODULIN; LUMICAN; MIMECAN; PERLECAN; PROTEOGLYCAN; VERSICAN;

ADULT; AGED; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; BRUCH MEMBRANE; CHOROID; CONTROLLED STUDY; DENSITOMETRY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEOMICS; RETINA; SCLERA; TANDEM MASS SPECTROMETRY; CADAVER; CHEMISTRY; COMPARATIVE STUDY; FLUORESCENCE MICROSCOPY; ION EXCHANGE CHROMATOGRAPHY; MASS SPECTROMETRY; METHODOLOGY; MIDDLE AGED;

AGED; AGED, 80 AND OVER; CADAVER; CHOROID; CHROMATOGRAPHY, ION EXCHANGE; HUMANS; MASS SPECTROMETRY; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; PROTEOGLYCANS; PROTEOMICS; RETINA; SCLERA;

EID: 84872193660     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10797     Document Type: Article

References (60)

1. Sarrazin S, Lamanna WC, Esko JD. Heparan sulfate proteogly-cans. Cold Spring Harb Perspect Biol. 2011;3:pii:a004952.
2. Iozzo RV, Schaefer L. Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J. 2010;277:3864-3875.
3. Inatani M, Tanihara H. Proteoglycans in retina. Prog Ret Eye Res. 2002;21:429-447.
4. Schaefer L, Schaefer RM. Proteoglycans: from structural compounds to signaling molecules. Cell Tissue Res. 2010; 339:237-246.
5. Ichijo H. Proteoglycans as cues for axonal guidance in formation of retinoctectal or retinocollicular projections. Mol Neurobiol. 2004;30:23-33.
6. Lazarus HS, Hageman GS. Xyloside-induced disruption of interphotoreceptor matrix proteoglycans results in retinal detachment. Invest Ophthalmol Vis Sci. 1992;33:364-376.
7. Booij JC, Baas DC, Beisekeeva J, et al. The dynamic nature of Bruch's membrane. Prog Ret Eye Res. 2010;29:1-18.
8. Clark SJ, Perveen R, Hakobyan S, et al. Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina. J Biol Chem. 2010;285:30192-30202.
9. Clark SJ, Bishop PN, Day AJ. Complement factor H and age-related macular degeneration: the role of glycosaminoglycan recognition in disease pathology. Biochem Soc Trans. 2010;38: 1342-1348.
10. Day AJ, Clark SJ, Bishop PN. Understanding the molecular basis of age-related macular degeneration and how the identification of new mechanisms may aid the development of novel therapies. Expert Rev Ophthalmol. 2011;6:123-128.
11. Clark SJ, Keenan TDL, Fielder H, et al. Mapping the differential distribution of glycosaminoglycans in the adult human retina, choroid and sclera. Invest Ophthalmol Vis Sci. 2011;52:6511-6521.
12. Ali SA, Hosaka YZ, Uehara M. Spatiotemporal distribution of chondroitin sulfate proteoglycans in the developing mouse retina and optic nerve. J Vet Med Sci. 2011;73:13-18.
13. Popp S, Maurel P, Andersen JS, Margolis RU. Developmental changes of aggrecan, versican and neurocan in the retina and optic nerve. Exp Eye Res. 2004;79:351-356.
14. Zako M, Shinomura T, Miyaishi O, et al. Transient expression of PG-M/versican, a large chondroitin sulfate proteoglycan in developing chicken retina. J Neurochem. 1997;69:2155-2161.
15. McAdams BD, McLoon SC. Expression of chondroitin sulfate and keratan sulfate proteoglycans in the path of growing retinal axons in the developing chick. J Comp Neurol. 1995; 352:594-606.
16. Johnson PT, Betts KE, Radeke MJ, et al. Individuals homozy-gous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc Natl Acad Sci U S A. 2006;103:17456-17461.
17. Halfter W, Dong S, Schurer B, et al. Embryonic synthesis of the inner limiting membrane and vitreous body. Invest Ophthal-mol Vis Sci. 2005;46:2202-2209.
18. Bhutto IA, Kim SY, McLeod DS, et al. Localization of collagen XVIII and the endostatin portion of collagen XVIII in aged human control eyes and eyes with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2004;45:1544-1552.
19. Witmer AN, van den Born J, Vrensen GFJM, Schlingemann RO. Vascular localization of heparan sulfate proteoglycans in retinas of patients with diabetes mellitus and in VEGF-induced retinopathy using domain-specific antibodies. Curr Eye Res. 2001;22:190-197.
20. Wall RS, Gyi TJ. Alcian blue staining of proteoglycans in polyacrylamide gels using the critical electrolyte concentration approach. Analytical Biochem. 1988;175:298-299.
21. Pierce A, Williamson A, Jaworska E, et al. Identification of nuclear protein targets for six leukemogenic tyrosine kinases governed by post-translational regulation. PLoS One. 2012;7: e38928.
22. Halfter W. A heparan sulfate proteoglycan in developing avian axonal tracts. J Neurosci. 1993;13:2863-2873.
23. Isogai Z, Shinomura T, Yamakawa N, et al. 2B1 antigen characteristically expressed on extracellular matrices of human malignant tumors is a large chondroitin sulfate proteoglycan, PG-M/versican. Cancer Res. 1996;56:3902-3908.
24. Asher RA, Mergenstern DA, Shearer MC, et al. Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells. J Neurosci. 2002;22:2225-2236.
25. Virgintino D, Perissinotto D, Girolamo F, et al. Differential distribution of aggrecan isoforms in perineuronal nets of the human cerebral cortex. J Cell Mol Med. 2009;13:3151-3173.
26. Dudhia J, Davidson CM, Wells TM, et al. Age-related changes in the content of the C-terminal region of aggrecan in human articular cartilage. Biochem J. 1996;313:933-940.
27. R&D Systems, Inc. Monoclonal anti-human brevican antibody. Available at: http://www.rndsystems.com/pdf/MAB40091.pdf. Accessed July 12, 2012.
28. Brézillon S, Venteo L, Ramont L, et al. Expression of lumican, a small leucine-rich proteoglycan with antitumour activity, in human malignant melanoma. Clin Exp Dermatol. 2007;32: 405-416.
29. Kitaya K, Yasuo T. Dermatan sulfate proteoglycan biglycan as a potential selectin L/CD44 ligand involved in selective recruitment of peripheral blood CD16(-) natural killer cells into human endometrium. J Leukoc Biol. 2009;85:391-400.
30. Zhang Y, Conrad AH, Conrad GW. Effects of ultraviolet-A and riboflavin on the interaction of collagen and proteoglycans during corneal cross-linking. J Biol Chem. 2011;286:13011-13022.
31. R&D Systems, Inc. Human mimecan antibody. Available at: http://www.rndsystems.com/pdf/MAB2660.pdf. Accessed July 12, 2012.
32. Abcam, Inc. Anti-PRELP antibody. Available at: http://www. abcam.com/PRELP-antibody-ab76511.pdf. Accessed July 12, 2012.
33. Goff MM, Lu H, Ugarte M, et al. The vitreous glycoprotein opticin inhibits preretinal neovascularisation. Invest Ophthal-mol Vis Sci. 2012;53:228-234.
34. Adamczyk C, Milz S, Tischer T, Putz R, Benjamin M. An immunohistochemical study of the extracellular matrix of entheses associated with the human pisiform bone. J Anat. 2008;212:645-653.
35. Rosenberg WM, Prince C, Kaklamanis L, et al. Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease. Lancet. 1995;345:1205-1209.
36. Milz S, Regner F, Putz R, Benjamin M. Expression of a wide range of extracellular matrix molecules in the tendon and trochlea of the human superior oblique muscle. Invest Ophthalmol Vis Sci. 2002;43:1330-1334.
37. Binette F, Cravens J, Kahoussi B, Haudenschild DR, Goetinck PF. Link protein is ubiquitously expressed in non-cartilaginous tissues where it enhances and stabilizes the interaction of proteoglycans with hyaluronic acid. J Biol Chem. 1994;269: 19116-19122.
38. Rada JA, Achen VR, Perry CA, Fox PW. Proteoglycans in the human sclera. Evidence for the presence of aggrecan. Invest Ophthalmol Vis Sci. 1997;38:1740-1751.
39. Theocharis AD, Skandalis, SS, Tzanakakis GN, Karamanos NK. Proteoglycans in health and disease: novel roles for proteo-glycans in malignancy and their pharmacological targeting. FEBS J. 2010;277:3904-3923.
40. Jackson DG, Bell JI, Dickinson R, Timans J, Shields J, Whittle N. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol. 1995;128:673-685.
41. Roepstorff P. Mass spectrometry based proteomics, background, status and future needs. Protein Cell. 2012;3:641-647.
42. Yuan X, Gu X, Crabb JS, et al. Quantitative proteomics: comparison of the macular Bruch membrane/choroid complex from age-related macular degeneration and normal eyes. Mol Cell Proteomics. 2010;9:1031-1046.
43. Sertie AL, Sossi V, Camargo AA, et al. Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal structure and in neural tube closure (Knobloch syndrome). Hum Mol Genet. 2000;9:2051-2058.
44. Goyal A, Pal N, Concannon M, et al. Endorepellin, the angiostatic module of perlecan, interacts with both the a2b1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonism. J Biol Chem. 2011; 286:25947-25962.
45. Reardon A, Heinegård D, McLeod D, Sheehan JK, Bishop PN. The large chondroitin sulphate proteoglycan versican in mammalian vitreous. Matrix Biol. 1998;17:325-333.
46. Meredith SP, Richards AJ, Flanagan DW, Scott JD, Poulson AV, Snead MP. Clinical characterisation and molecular analysis of Wagner syndrome. Br J Ophthalmol. 2007;91:655-659.
47. Inatani M, Tanihara H, Honjo M, Hangai M, Kresse H, Honda Y. Expression of proteoglycan decorin in neural retina. Invest Ophthalmol Vis Sci. 1999;40:1783-1791.
48. Zagris N, Gilipathi K, Soulintzi N, Konstantopoulos K. Decorin developmental expression and function in the early avian embryo. Int J Dev Biol. 2011;55:633-639.
49. Sallo FB, Bereczki E, Csont T, et al. Bruch's membrane changes in transgenic mice overexpressing the human biglycan and apolipoprotein b-100 genes. Exp Eye Res. 2009;89:178-186.
50. Johnson JM, Young TL, Rada JA. Small leucine rich repeat proteoglycans (SLRPs) in the human sclera: identification of abundant levels of PRELP. Mol Vis. 2006;12:1057-1066.
51. Chakravarti S, Petroll WM, Hassell JR, et al. Corneal opacity in lumican-null mice: defects in collagen fibril structure and packing in the posterior stroma. Invest Ophthalmol Vis Sci. 2000;41:3365-3373.
52. Ying S, Shiraishi A, Kao CW, et al. Characterization and expression of the mouse lumican gene. J Biol Chem. 1997; 272:30306-30313.
53. 0-UTR polymorphism with high myopia. Invest Ophthalmol Vis Sci. 2010;51:96-102.
54. Chakravarti S, Paul J, Roberts L, Chervoneva I, Oldberg A, Birk DE. Ocular and scleral alterations in gene-targeted lumican-fibromodulin double-null mice. Invest Ophthalmol Vis Sci. 2003;44:2422-2432.
55. Ramesh S, Bonshek RE, Bishop PN. Immunolocalisation of opticin in the human eye. Br J Ophthalmol. 2004;88:697-702.
56. Bishop PN, Takanosu M, Le Goff M, et al. The role of the posterior ciliary body in the biosynthesis of vitreous humour. Eye. 2002;16:454-460.
57. Le Goff MM, Sutton MJ, Slevin M, Latif A, Humphries MJ, Bishop PN. Opticin exerts its anti-angiogenic activity by regulating extracellular matrix adhesiveness. J Biol Chem. 2012;287:28027-28036.
58. Tsonis PA, Goetinck PF. Expression of cartilage-matrix genes and localization of their translation products in the embryonic chick eye. Exp Eye Res. 1988;46:753-764.
59. Carulli D, Pizzorusso T, Kwok JC, et al. Animals lacking link protein have attenuated perineuronal nets and persistent plasticity. Brain. 2010;133:2331-2347.
60. Matrix Science, Inc. Matrix Science. Available at: http://www. matrixscience.com. Accessed July 12, 2012.